Company: MYGN
Filing Date: 2025-11-04
Form Type: 10-Q
Source: 0000899923-25-000112
Chunk: 75

Company: MYRIAD GENETICS INC
Filing Date: 2025-11-04
Form: 10-Q
Item: Part I, Item 8
Chunk 75
---
 Women’s Health reporting unit, reducing the carrying value of goodwill for these reporting units to their estimated fair values. The Company determined that the goodwill balance for the International reporting unit was not impaired. The goodwill impairment charges are reflected in Goodwill and long-lived asset impairment charges in the Condensed Consolidated Statements of Operations. The remaining goodwill value of $51.6 million consists of $29.8 million for the Pharmacogenomics reporting unit, $17.3 million for the International reporting unit and $4.5 million for the Women's Health reporting unit.      Management will continue to monitor for any additional indicators of impairment in future periods. Goodwill is tested for impairment at least annually and more frequently if events or changes in circumstances indicate that it is more likely than not that the asset is impaired.Intangible AssetsThe following tables summarize the amounts reported as intangible assets:(in millions)GrossCarryingAmount(1)AccumulatedAmortizationNetAt September 30, 2025Developed technologies$480.2 $(347.7)$132.5 Internal-use software$21.9 $(3.1)$18.8 Trademarks$2.1 $(1.6)$0.5 Licensed technologies$5.3 $(0.4)$4.9 Internal-use software (in-process)$6.4 $— $6.4 Total intangible assets$515.9 $(352.8)$163.1 (1)Net of $82.0 million in impairment expense recognized in the three months ended June 30, 2025.  See the discussion below for further details regarding the impairment of intangible assets.  (in millions)GrossCarryingAmountAccumulatedAmortizationNetAt December 31, 2024Developed technologies$560.1 $(326.5)$233.6 Internal-use software1.8(0.7)$1.1 Customer relationships1.6(0.3)1.3 Trademarks6.1(1.3)4.8 Internal-use software (in-process)21.6— $21.6 Total intangible assets$591.2 $(328.8)$262.4 As noted above, the Company experienced a sustained decline in its market capitalization during the three months ended June 30, 2025, which triggered the Company to perform a recoverability test for certain of